Neuronetics Launches Improved Version – GuruFocus.com

0


MALVERN, Pa., July 14, 2021 (GLOBE NEWSWIRE) – Neuronetics, Inc. (STEM), a commercial-stage medical technology company focused on the design, development and commercialization of products that improve the quality of life of patients with psychiatric disorders, announced the launch of its new My NeuroStar resource center, now online at www.MyNeuroStar.com. Created for current NeuroStar providers, the updated digital portal gives physicians the resources and tools they need to grow their practice through marketing and advertising, strengthen referral relationships, and help more patients benefit from NeuroStar advanced therapy for mental health, a non-drug, non-treatment of depression by invasive transcranial magnetic stimulation (TMS).

“At NeuroStar, we are more committed than ever to ensuring that practices have all the marketing materials and support they need to effectively educate the growing number of people seeking treatment,” said Janie Bates, vice president of marketing at Neuronetics. “Our readily available marketing and training resources will help increase the number of treatments nationwide, further propelling our mission to transform as many lives as possible.”

My NeuroStar Resource Center provides 900 NeuroStar practices across the country with an easy way to access customizable material, included in their NeuroStar program, allowing them to manage their marketing efforts and patient education programs with support from Neuronetics, the TMS market leader. Resource Center redesigned to dramatically improve user experience and host new media including NeuroStar brand logos, videos, social media posts, plug-and-play assets for the co-op marketing program from NeuroStar and more. The improvements come at a time when physicians seek to optimize patient care and increase awareness of and access to innovative treatments for depression like NeuroStar.

Customizable digital and print resources – including over 25 templates for announcements, invitations, certificates and brochures – are also available for users, who can easily add their firm’s logo to available documents using the site’s digital software. Web. In addition, practices now have team training materials at their fingertips and access to top-notch programs that help them succeed, such as NeuroStar’s exclusive 5-STARS to Success program and Precision Pulse. with cooperative marketing.

Other key features include:

  • Create your own templates for ads and social media
  • Website branding examples and tips
  • Patient story videos
  • Brand and product photos
  • Best practice training videos
  • Models of communication with physicians and referrals

“Mental health awareness has increased dramatically over the past year and it’s important to keep the conversation going,” said Manuj Nangia, MD, medical director of the San Jose Integrative Wellness Center. “Practices must seize the opportunity to expand the reach of patients with depression interested in non-drug treatments, and the resources provided in the MyNeuroStar portal make the process much easier. Comprehensive marketing and practice management supports provide turnkey solutions and make Neuronetics a trusted ally for TMS providers.

17.3 million Americans1 currently suffer from depression, and the updated My NeuroStar resource center better equips self-defense practices. To learn more, visit www.neurostar.com.

About neuronetics
Neuronetics, Inc. is a commercial-stage medical technology company focused on the design, development and commercialization of products that improve the quality of life for patients with psychiatric disorders. Its commercial product, NeuroStar® Advanced Therapy for Mental Health, is a non-invasive, non-systemic office treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed magnetic field of MRI strength that induces electrical currents designed to stimulate specific areas of the brain associated with mood. NeuroStar is cleared by the United States Food and Drug Administration, or FDA, for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from previous antidepressant therapy in the episode current. Visit NeuroStar.com for safety information and directions for use. NeuroStar is also available in other parts of the world, including Japan, where it is listed under the National Health Insurance of Japan. Additional information can be found at www.neuronetics.com.

Media contact:
EvolveMKD
646.517.4220
[email protected]

1 https://www.nimh.nih.gov/health/statistics/major-depression.shtml, accessed 5/24/21

172b48fb-7f7f-469c-9477-21ed3d4f6249



Source link

Leave A Reply

Your email address will not be published.